Aqr Arbitrage LLC Catalent, Inc. Transaction History

Aqr Arbitrage LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $8.64 Million - $9.38 Million	153,924 Added 42.98%	512,091 $31 Million
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $9.45 Million - $10.1 Million	-176,379 Reduced 33.0%	358,167 $20.1 Million
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $22.8 Million - $32 Million	534,546 New	534,546 $30.2 Million

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Aqr Arbitrage LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Arbitrage LLC with notifications on news.